Moody Aldrich Partners LLC Meridian Bioscience Inc Transaction History

Moody Aldrich Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$17.35 - $22.5 $2.38 Million - $3.08 Million	-137,075 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$18.01 - $28.32 $31,859 - $50,098	-1,769 Reduced 1.27%	137,075 $3.04 Million
Q1 2021 May 10, 2021	BUY	$19.76 - $29.89 $58,746 - $88,862	2,973 Added 2.19%	138,844 $3.65 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $12,253 - $16,873	-779 Reduced 0.57%	135,871 $2.54 Million
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $1.1 Million - $2.15 Million	81,440 Added 147.51%	136,650 $2.32 Million
Q2 2020 Jul 30, 2020	BUY	$7.84 - $23.29 $432,846 - $1.29 Million	55,210 New	55,210 $1.29 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.